Skip to content

Inflammation Reduction Through Inhalation of conditioned Medium

A Study on the Suppression of lnfiammation Through Inhalation Administration of Human- Derived Mcsenchymal Stem Cell Conditioned Medium

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1051240290
Enrollment
Unknown
Registered
2025-03-11
Start date
2025-03-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic infiammation

Interventions

None listed

Sponsors

Inami Norihito
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Individuals who arc concemed about diseases thought to be caused by infiammation and arc not satisfied with conventional treatments. 2.Individuals who do not wish to undergo treatment with standard medications due to concerns about sidc cffects, and have been determined by a doctor to be suitable for treatment with conditioned medium from human- derived mesenchymal stem cells. Application Criteria: Patients who meet the following criteria arc cligible: 1.Individuals aged 18 years or older. 2.Individuals with a CRP (C-reactive protein) level of 0.3 mg/dL or higher upon initial evaluation. 3.Individuals who possess normal capacity to consnt. 4.Individuals who have been given a thorough explanation and have received an informed consent document related to this treatment,and can provide written voluntarily.

Exclusion criteria

Exclusion criteria: Exclusion Criteria: Individuals who meet any of the following conditions will be excluded: 1.Users of narcotics or stimulants. 2.Individuals who know they cannot visit the clinic once a week. 3..Individuals deemed unsuitable by the attending doctor.

Design outcomes

Primary

MeasureTime frame
Measurement of CRP, GDF15, and Klotho

Secondary

MeasureTime frame
subjective symptoms, etc.

Contacts

Public ContactNorihito Inami

Seihoku Clinic

ikami@shhc.jp+81-78-998-1101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026